US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ATS Corp.

19.31

-0.1200-0.62%

Volume:125.58K

Turnover:2.43M

Market Cap:1.89B

PE:57.43

High:19.47

Open:19.39

Low:19.16

Close:19.43

52wk High:35.82

52wk Low:18.41

Shares:98.13M

Float Shares:74.29M

Volume Ratio:0.44

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3362

EPS(LYR):0.5242

ROE:2.69%

ROA:2.92%

PB:1.46

PE(LYR):36.83

Loading ...

Overview Company News Filings

GUIDANCE: (ATS) ATS Expects Fiscal Q1 Revenue Range CA$700M to CA$740M

MT Newswires Live

Earnings Flash (ATS) ATS Posts Fiscal Q4 Revenue CA$747.1M

MT Newswires Live

ATS Q4 Adj. EPS $0.36 Beats $0.32 Estimate, Sales $744.300M Beat $546.610M Estimate

Benzinga Earnings

Calendar of U.S. Earnings Expected in the Week Ahead

Press Release: ATS Reports Fourth Quarter Fiscal 2026 Results

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

Earning Preview: ATS Corp. this quarter’s revenue is expected to increase by 6.68%, and institutional views are bullish

MiNK Therapeutics reports new data on agenT-797 at ATS 2026

MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications

Savara presents poster at ATS 2026 International Conference on IMPALA-2

Entravision Rides ATS Surge in Latest Earnings Call

BLUE OCEAN TECHNOLOGIES APPOINTS WILLIAM GOODBODY, JR. AS HEAD OF MARKET OPERATIONS FOR BLUE OCEAN ATS IN AUSTRALIA

Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment

Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing

Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference

ATS Corporation Sets May 28, 2026 Fourth-Quarter Earnings Call

Wave Life Sciences ATS Data Could Support RNA Editing Platform, Wedbush Says

MT Newswires Live

Press Release: MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation

Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/ATS/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATS\",,,,,undefined,":{"symbol":"ATS","market":"US","secType":"STK","nameCN":"ATS Corp.","latestPrice":19.31,"timestamp":1789495234151,"preClose":19.43,"halted":0,"volume":125577,"delay":0,"changeRate":-0.006176016469377303,"floatShares":74294500,"shares":98126900,"eps":0.336239,"marketStatus":"Trading","change":-0.12,"latestTime":"09-15 14:00:48 EDT","open":19.39,"high":19.465,"low":19.16,"amount":2425013.930844,"amplitude":0.015697,"askPrice":19.31,"askSize":300,"bidPrice":19.3,"bidSize":99,"shortable":3,"etf":0,"ttmEps":0.336239,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"listingDate":1684987200000,"exchange":"NYSE","adjPreClose":19.43,"postHourTrading":{"tag":"盘后","latestPrice":19.43,"preClose":19.43,"latestTime":"19:30 EDT","volume":46295,"amount":899074.47012,"timestamp":1789428606716,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.444773,"impliedVol":0.3309,"impliedVolPercentile":0.247},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATS\",,,,,undefined,":{"symbol":"ATS","floatShares":74294500,"roa":"2.92%","roe":"2.69%","lyrEps":0.524235,"volumeRatio":0.444773,"shares":98126900,"dividePrice":0,"high":19.465,"amplitude":0.015697,"preClose":19.43,"low":19.16,"week52Low":18.41,"pbRate":"1.46","psRate":"0.90","week52High":35.82,"institutionHeld":0,"latestPrice":19.31,"committee":-0.503759,"eps":0.336239,"divideRate":0,"volume":125577,"delay":0,"ttmEps":0.336239,"open":19.39,"prevYearClose":27.54,"prevWeekClose":19.2,"prevMonthClose":19.26,"prevQuarterClose":28.78,"fiveDayClose":19.43,"twentyDayClose":19.59,"sixtyDayClose":28.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ATS","fiscalQuarterEnding":"2026/06","expectedEps":0.28,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":0.25},{"market":"US","date":"2026-05-28","symbol":"ATS","fiscalQuarterEnding":"2026/03","expectedEps":0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1779940800000,"reportTimeType":"pre","actualEps":0.26},{"market":"US","date":"2026-02-04","symbol":"ATS","fiscalQuarterEnding":"2025/12","expectedEps":0.3,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770181200000,"reportTimeType":"pre","actualEps":0.23},{"market":"US","date":"2025-11-05","symbol":"ATS","fiscalQuarterEnding":"2025/09","expectedEps":0.31,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":0.33},{"market":"US","date":"2025-08-07","symbol":"ATS","fiscalQuarterEnding":"2025/06","expectedEps":0.27,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0,"sell":1,"strongSell":0,"meanLabel":"SELL","meanPercent":1,"analysts":1,"updateTime":1771646400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATS","date":"2026-09-14","current":57.48887,"percent":0.860902,"low":-897.033197,"twenty":-92.254352,"median":33.415912,"eighty":48.206457,"high":254.533797,"avg":-31.19131,"sd":237.970759,"marketCap":1850916321.27},"quantilePoints":[{"date":"2023-06-02","current":46.343344,"twenty":46.194425,"median":46.266425,"eighty":46.306886,"marketCap":4385290976.46},{"date":"2023-06-09","current":46.009827,"twenty":46.17581,"median":46.28258,"eighty":46.915752,"marketCap":4390539453.8},{"date":"2023-06-16","current":45.438012,"twenty":45.320112,"median":46.164952,"eighty":46.476751,"marketCap":4375388926.84},{"date":"2023-06-23","current":48.145057,"twenty":45.487654,"median":46.266425,"eighty":47.860268,"marketCap":4658766213.85},{"date":"2023-06-30","current":46.896248,"twenty":45.651659,"median":46.266425,"eighty":47.485058,"marketCap":4511580364.18},{"date":"2023-07-07","current":46.270844,"twenty":46.009827,"median":46.312962,"eighty":47.5378,"marketCap":4411747145.22},{"date":"2023-07-14","current":48.698172,"twenty":46.043025,"median":46.511353,"eighty":47.780498,"marketCap":4728914205.59},{"date":"2023-07-21","current":48.480908,"twenty":46.105078,"median":46.872979,"eighty":48.286922,"marketCap":4686318579.71},{"date":"2023-07-28","current":45.850462,"twenty":46.043025,"median":46.851428,"eighty":48.286922,"marketCap":4428020690.86},{"date":"2023-08-04","current":44.368411,"twenty":46.009827,"median":46.763285,"eighty":48.152813,"marketCap":4237745227.85},{"date":"2023-08-11","current":42.700705,"twenty":45.438012,"median":46.511353,"eighty":48.145057,"marketCap":4326916372.16},{"date":"2023-08-18","current":40.050115,"twenty":44.926078,"median":46.32649,"eighty":48.075247,"marketCap":4021626143.41},{"date":"2023-08-25","current":41.899702,"twenty":43.443089,"median":46.270844,"eighty":48.061899,"marketCap":4194356348.69},{"date":"2023-08-31","current":43.312379,"twenty":42.678859,"median":46.219245,"eighty":47.836778,"marketCap":4344740041.37},{"date":"2023-09-08","current":43.843953,"twenty":42.897314,"median":46.105078,"eighty":47.634879,"marketCap":4353234860.78},{"date":"2023-09-15","current":43.042951,"twenty":42.657014,"median":45.930144,"eighty":47.433983,"marketCap":4325894000.62},{"date":"2023-09-22","current":41.921548,"twenty":42.559437,"median":45.562117,"eighty":47.311701,"marketCap":4220969734.92},{"date":"2023-09-29","current":42.533222,"twenty":42.508464,"median":45.081733,"eighty":47.274981,"marketCap":4280367687.17},{"date":"2023-10-06","current":40.050115,"twenty":42.428364,"median":44.926078,"eighty":47.160162,"marketCap":3958860964.51},{"date":"2023-10-13","current":39.423877,"twenty":42.00893,"median":44.615828,"eighty":47.035061,"marketCap":3917634187.34},{"date":"2023-10-20","current":36.088795,"twenty":41.126371,"median":44.229891,"eighty":46.935301,"marketCap":3572025991.12},{"date":"2023-10-27","current":34.661554,"twenty":40.778231,"median":44.058847,"eighty":46.909266,"marketCap":3403618402.31},{"date":"2023-11-03","current":33.358105,"twenty":40.050115,"median":43.843953,"eighty":46.860392,"marketCap":3284508208.07},{"date":"2023-11-10","current":31.05346,"twenty":39.978754,"median":43.47968,"eighty":46.850053,"marketCap":3541182846.54},{"date":"2023-11-17","current":33.712074,"twenty":39.645245,"median":43.312379,"eighty":46.711431,"marketCap":3845894896.75},{"date":"2023-11-24","current":33.592349,"twenty":38.190334,"median":43.072078,"eighty":46.623309,"marketCap":3848769791.51},{"date":"2023-12-01","current":33.655362,"twenty":35.166914,"median":42.886392,"eighty":46.541855,"marketCap":3891785593.98},{"date":"2023-12-08","current":33.604952,"twenty":34.322082,"median":42.591477,"eighty":46.44537,"marketCap":3879525100.59},{"date":"2023-12-15","current":35.923838,"twenty":34.218738,"median":42.507736,"eighty":46.366559,"marketCap":4204253502},{"date":"2023-12-22","current":36.07507,"twenty":34.272496,"median":42.474968,"eighty":46.323119,"marketCap":4257700834.69},{"date":"2023-12-29","current":36.289315,"twenty":34.310293,"median":42.423994,"eighty":46.304224,"marketCap":4315633982.44},{"date":"2024-01-05","current":34.650971,"twenty":34.327977,"median":42.161849,"eighty":46.287991,"marketCap":4072504954.25},{"date":"2024-01-12","current":35.442932,"twenty":34.397952,"median":41.910625,"eighty":46.273191,"marketCap":4139113955.77},{"date":"2024-01-19","current":36.274955,"twenty":34.423844,"median":41.655761,"eighty":46.2585,"marketCap":4216951441.35},{"date":"2024-01-26","current":36.917882,"twenty":34.562753,"median":40.778299,"eighty":46.231655,"marketCap":4292072985.19},{"date":"2024-02-02","current":36.987217,"twenty":34.654752,"median":40.235802,"eighty":46.154093,"marketCap":4330447033.68},{"date":"2024-02-09","current":31.2472,"twenty":34.423844,"median":40.050115,"eighty":46.10731,"marketCap":4053209917.9},{"date":"2024-02-16","current":29.911027,"twenty":34.218738,"median":40.010065,"eighty":46.067846,"marketCap":3869003534.07},{"date":"2024-02-23","current":28.569192,"twenty":34.062459,"median":39.908119,"eighty":46.029746,"marketCap":3697982548.6},{"date":"2024-03-01","current":28.954191,"twenty":33.729718,"median":39.700587,"eighty":45.946081,"marketCap":3727658474.68},{"date":"2024-03-08","current":28.897573,"twenty":33.622723,"median":38.630157,"eighty":45.760452,"marketCap":3749905081.21},{"date":"2024-03-15","current":28.33706,"twenty":33.535637,"median":37.535596,"eighty":45.60011,"marketCap":3663186667.6},{"date":"2024-03-22","current":28.378306,"twenty":33.360741,"median":37.125888,"eighty":45.512475,"marketCap":3664397837.7},{"date":"2024-03-28","current":27.463826,"twenty":33.187804,"median":36.956482,"eighty":45.379062,"marketCap":3545999564.77},{"date":"2024-04-05","current":25.261057,"twenty":31.829239,"median":36.880063,"eighty":45.11865,"marketCap":3270651387.12},{"date":"2024-04-12","current":24.173756,"twenty":30.404732,"median":36.432536,"eighty":45.004481,"marketCap":3078077137.88},{"date":"2024-04-19","current":24.609778,"twenty":29.677763,"median":36.289315,"eighty":44.938488,"marketCap":3127556802.58},{"date":"2024-04-26","current":25.396884,"twenty":29.011941,"median":36.169269,"eighty":44.868397,"marketCap":3239367008.29},{"date":"2024-05-03","current":25.125077,"twenty":28.84322,"median":36.062467,"eighty":44.633305,"marketCap":3203669221.23},{"date":"2024-05-10","current":26.025435,"twenty":28.633736,"median":35.997283,"eighty":44.566345,"marketCap":3323128791.91},{"date":"2024-05-17","current":23.786609,"twenty":28.457413,"median":35.841921,"eighty":44.342163,"marketCap":3384597470.53},{"date":"2024-05-24","current":21.936652,"twenty":28.195987,"median":35.701363,"eighty":44.23426,"marketCap":3102092113.2},{"date":"2024-05-31","current":21.435159,"twenty":27.970637,"median":35.598334,"eighty":44.222609,"marketCap":3039383806.02},{"date":"2024-06-07","current":22.690097,"twenty":27.463826,"median":35.382456,"eighty":43.895086,"marketCap":3211638521.11},{"date":"2024-06-14","current":22.285278,"twenty":26.048085,"median":35.173981,"eighty":43.895086,"marketCap":3139567043.35},{"date":"2024-06-21","current":21.323834,"twenty":25.875989,"median":34.8436,"eighty":43.864406,"marketCap":3015344623.92},{"date":"2024-06-28","current":22.482628,"twenty":25.849972,"median":34.751792,"eighty":43.843953,"marketCap":3180274284.27},{"date":"2024-07-05","current":21.972427,"twenty":25.639244,"median":34.657272,"eighty":43.651713,"marketCap":3127376247.29},{"date":"2024-07-12","current":22.998515,"twenty":25.494281,"median":34.422199,"eighty":43.533747,"marketCap":3270585876.4},{"date":"2024-07-15","current":22.953023,"twenty":25.430859,"median":34.413972,"eighty":43.516271,"marketCap":3254489261.98},{"date":"2024-08-02","current":20.309458,"twenty":25.403679,"median":34.373922,"eighty":43.501635,"marketCap":2841766295.19},{"date":"2024-08-09","current":20.723514,"twenty":25.129607,"median":34.224644,"eighty":43.440249,"marketCap":2735666122.5},{"date":"2024-08-16","current":19.860035,"twenty":24.796645,"median":34.162619,"eighty":43.405587,"marketCap":2630022203.9},{"date":"2024-08-23","current":19.838448,"twenty":24.268888,"median":33.920018,"eighty":43.283252,"marketCap":2645505418.49},{"date":"2024-08-30","current":19.471469,"twenty":23.8321,"median":33.734128,"eighty":43.147809,"marketCap":2621186477.04},{"date":"2024-09-06","current":18.602592,"twenty":23.494241,"median":33.671115,"eighty":43.072078,"marketCap":2495925620.93},{"date":"2024-09-13","current":19.185441,"twenty":22.907687,"median":33.604952,"eighty":43.042951,"marketCap":2560815499.76},{"date":"2024-09-20","current":20.831449,"twenty":22.803751,"median":33.570295,"eighty":43.028387,"marketCap":2786196948.41},{"date":"2024-09-27","current":21.948725,"twenty":22.594145,"median":33.45372,"eighty":42.744396,"marketCap":2956487278.6},{"date":"2024-10-04","current":21.646505,"twenty":22.472834,"median":33.3614,"eighty":42.700705,"marketCap":2900362552.24},{"date":"2024-10-11","current":21.560157,"twenty":22.285278,"median":33.233174,"eighty":42.591477,"marketCap":2843647655.11},{"date":"2024-10-18","current":22.617927,"twenty":22.261739,"median":32.698187,"eighty":42.533222,"marketCap":2977792893.11},{"date":"2024-10-25","current":22.645897,"twenty":22.285278,"median":31.73976,"eighty":42.511377,"marketCap":2967565955.08},{"date":"2024-10-31","current":23.088453,"twenty":22.329808,"median":31.05346,"eighty":42.505551,"marketCap":3006452868.32},{"date":"2024-11-08","current":30.478219,"twenty":22.389519,"median":30.568298,"eighty":42.486619,"marketCap":2853731574.85},{"date":"2024-11-15","current":30.530988,"twenty":22.401664,"median":30.478219,"eighty":42.476424,"marketCap":2830133907.78},{"date":"2024-11-22","current":30.757144,"twenty":22.402758,"median":30.568681,"eighty":42.451666,"marketCap":2862659955.58},{"date":"2024-11-29","current":33.961013,"twenty":22.434826,"median":30.673837,"eighty":42.419625,"marketCap":3148783777.17},{"date":"2024-12-06","current":34.669633,"twenty":22.46611,"median":30.907914,"eighty":42.257969,"marketCap":3210086264.85},{"date":"2024-12-13","current":33.207161,"twenty":22.47871,"median":31.108842,"eighty":42.148741,"marketCap":3040755582.89},{"date":"2024-12-20","current":31.48838,"twenty":22.488641,"median":31.48838,"eighty":42.00893,"marketCap":2849502272.41},{"date":"2024-12-27","current":33.734858,"twenty":22.494713,"median":31.970845,"eighty":41.91281,"marketCap":3041459063.87},{"date":"2025-01-03","current":33.410701,"twenty":22.507997,"median":32.326091,"eighty":41.867662,"marketCap":3006099952.21},{"date":"2025-01-10","current":30.583758,"twenty":22.548751,"median":32.187154,"eighty":41.739502,"marketCap":2758779888.76},{"date":"2025-01-17","current":28.714206,"twenty":22.594145,"median":31.76484,"eighty":41.57202,"marketCap":2591110278.91},{"date":"2025-01-24","current":30.922991,"twenty":22.613171,"median":31.446918,"eighty":40.977822,"marketCap":2794075415.08},{"date":"2025-01-31","current":29.754521,"twenty":22.627085,"median":31.164224,"eighty":40.788494,"marketCap":2682414705.78},{"date":"2025-02-07","current":44.52783,"twenty":22.642592,"median":31.108842,"eighty":40.977822,"marketCap":2778433490.84},{"date":"2025-02-14","current":46.096561,"twenty":22.681257,"median":31.405456,"eighty":41.965239,"marketCap":2894690862.79},{"date":"2025-02-21","current":45.29574,"twenty":22.741461,"median":31.73976,"eighty":42.419625,"marketCap":2847627453.27},{"date":"2025-02-28","current":46.79865,"twenty":22.792532,"median":32.079,"eighty":42.507008,"marketCap":2895255396.7},{"date":"2025-03-07","current":41.862084,"twenty":22.806185,"median":32.332694,"eighty":42.635168,"marketCap":2622361985.36},{"date":"2025-03-14","current":41.423278,"twenty":22.822194,"median":32.713389,"eighty":42.635168,"marketCap":2565848922.04},{"date":"2025-03-21","current":43.880591,"twenty":22.853037,"median":32.981006,"eighty":43.034213,"marketCap":2732813300.12},{"date":"2025-03-28","current":42.224099,"twenty":22.88278,"median":33.123373,"eighty":43.054602,"marketCap":2633489494.72},{"date":"2025-04-04","current":39.042756,"twenty":22.901877,"median":33.222238,"eighty":43.034213,"marketCap":2482102274.67},{"date":"2025-04-11","current":36.168577,"twenty":22.907687,"median":33.258379,"eighty":42.953904,"marketCap":2303349084},{"date":"2025-04-17","current":36.662234,"twenty":22.91307,"median":33.3614,"eighty":42.840307,"marketCap":2360722684.91},{"date":"2025-04-25","current":38.011562,"twenty":22.933896,"median":33.415912,"eighty":42.72692,"marketCap":2443342344.25},{"date":"2025-05-02","current":38.318726,"twenty":22.957542,"median":33.501164,"eighty":42.694361,"marketCap":2471450690},{"date":"2025-05-09","current":38.494248,"twenty":22.972956,"median":33.554541,"eighty":42.647498,"marketCap":2471983722.75},{"date":"2025-05-16","current":42.432532,"twenty":22.990951,"median":33.59865,"eighty":42.694361,"marketCap":2705638771.71},{"date":"2025-05-23","current":39.240219,"twenty":23.03449,"median":33.649379,"eighty":42.706785,"marketCap":2525720011.68},{"date":"2025-05-30","current":-145.081888,"twenty":22.98843,"median":33.649379,"eighty":42.736874,"marketCap":2948051518.8},{"date":"2025-06-06","current":-141.392185,"twenty":22.910379,"median":33.59865,"eighty":42.706785,"marketCap":2905577142.42},{"date":"2025-06-13","current":-147.065973,"twenty":22.838868,"median":33.554541,"eighty":42.705569,"marketCap":3029340885.66},{"date":"2025-06-20","current":-147.588101,"twenty":22.775703,"median":33.508702,"eighty":42.700705,"marketCap":3013637808.62},{"date":"2025-06-27","current":-151.382229,"twenty":22.617927,"median":33.434816,"eighty":42.684845,"marketCap":3112877198.05},{"date":"2025-07-03","current":-154.340953,"twenty":22.496776,"median":33.387698,"eighty":42.610151,"marketCap":3191028919.77},{"date":"2025-07-11","current":-140.452356,"twenty":22.445425,"median":33.283584,"eighty":42.544873,"marketCap":2878692397.63},{"date":"2025-07-18","current":-148.841207,"twenty":22.329808,"median":33.214699,"eighty":42.515746,"marketCap":3036782441.3},{"date":"2025-07-25","current":-150.163931,"twenty":22.224904,"median":33.070283,"eighty":42.505551,"marketCap":3090657544.76},{"date":"2025-08-01","current":-146.369803,"twenty":21.983688,"median":33.000575,"eighty":42.486619,"marketCap":2966528128.91},{"date":"2025-08-08","current":-101.054949,"twenty":21.94631,"median":32.80762,"eighty":42.476424,"marketCap":2880442495.37},{"date":"2025-08-15","current":-97.518773,"twenty":21.761929,"median":32.336463,"eighty":42.451666,"marketCap":2771168115.02},{"date":"2025-08-22","current":-92.314119,"twenty":21.629235,"median":32.187154,"eighty":42.435194,"marketCap":2605351661.45},{"date":"2025-08-29","current":-94.430844,"twenty":21.416942,"median":31.76484,"eighty":42.408226,"marketCap":2690809366.58},{"date":"2025-09-05","current":-94.231623,"twenty":21.21908,"median":31.446918,"eighty":42.295319,"marketCap":2669825633.28},{"date":"2025-09-12","current":-95.028508,"twenty":20.931914,"median":31.164224,"eighty":42.186749,"marketCap":2693629533.12},{"date":"2025-09-19","current":-96.921109,"twenty":20.265687,"median":30.941837,"eighty":42.148741,"marketCap":2753845197.92},{"date":"2025-09-26","current":-91.367818,"twenty":19.971207,"median":30.757144,"eighty":42.098311,"marketCap":2572349952.97},{"date":"2025-10-03","current":-91.467429,"twenty":19.836289,"median":30.673837,"eighty":41.981136,"marketCap":2565172507.46},{"date":"2025-10-10","current":-91.890774,"twenty":19.770448,"median":30.583758,"eighty":41.90844,"marketCap":2570628933.63},{"date":"2025-10-17","current":-92.538243,"twenty":19.536178,"median":30.429218,"eighty":41.877131,"marketCap":2583489123.67},{"date":"2025-10-24","current":-94.057305,"twenty":19.426136,"median":30.327448,"eighty":41.829173,"marketCap":2635618172.4},{"date":"2025-10-31","current":-92.861977,"twenty":19.191917,"median":30.172909,"eighty":41.766594,"marketCap":2604412516.09},{"date":"2025-11-07","current":-840.478534,"twenty":18.877826,"median":30.012938,"eighty":41.639013,"marketCap":2763562438.19},{"date":"2025-11-14","current":-794.27753,"twenty":-24.454255,"median":29.885544,"eighty":41.482775,"marketCap":2634611431.77},{"date":"2025-11-21","current":-720.44031,"twenty":-90.690466,"median":29.754521,"eighty":41.357457,"marketCap":2378964442.77},{"date":"2025-11-28","current":-749.131344,"twenty":-91.427585,"median":29.66191,"eighty":41.252143,"marketCap":2481656418.02},{"date":"2025-12-05","current":-772.548291,"twenty":-92.025248,"median":29.434134,"eighty":41.138054,"marketCap":2574939374.84},{"date":"2025-12-12","current":-806.302449,"twenty":-92.468515,"median":29.33919,"eighty":40.994795,"marketCap":2719740619.47},{"date":"2025-12-19","current":-802.71607,"twenty":-92.687659,"median":29.038708,"eighty":40.808883,"marketCap":2711086457.01},{"date":"2025-12-26","current":-818.116404,"twenty":-92.881899,"median":28.925882,"eighty":40.778231,"marketCap":2780190128.31},{"date":"2026-01-02","current":-797.652946,"twenty":-93.036296,"median":28.85511,"eighty":40.777958,"marketCap":2701366821.38},{"date":"2026-01-09","current":-829.523643,"twenty":-93.982597,"median":28.79,"eighty":40.732159,"marketCap":2780572966.83},{"date":"2026-01-16","current":-897.033197,"twenty":-94.20672,"median":28.721744,"eighty":40.421489,"marketCap":3000957491.22},{"date":"2026-01-23","current":-852.94102,"twenty":-94.306331,"median":28.652131,"eighty":40.345308,"marketCap":2872825063.23},{"date":"2026-01-30","current":-822.139786,"twenty":-94.500572,"median":28.625809,"eighty":40.26483,"marketCap":2822985227.98},{"date":"2026-02-06","current":208.384924,"twenty":-94.699793,"median":28.600331,"eighty":40.345308,"marketCap":2876417798.07},{"date":"2026-02-13","current":217.783795,"twenty":-94.679871,"median":28.638821,"eighty":40.788494,"marketCap":3016893475.65},{"date":"2026-02-20","current":231.284936,"twenty":-94.545397,"median":28.714206,"eighty":41.221427,"marketCap":3190649761.48},{"date":"2026-02-27","current":231.233009,"twenty":-94.440805,"median":28.789796,"eighty":41.766594,"marketCap":3191752106.95},{"date":"2026-03-06","current":221.5745,"twenty":-94.430844,"median":28.835294,"eighty":41.981136,"marketCap":3051363607.19},{"date":"2026-03-13","current":200.855441,"twenty":-94.356136,"median":28.925882,"eighty":42.295319,"marketCap":2784391762.71},{"date":"2026-03-20","current":221.5745,"twenty":-94.306331,"median":29.083593,"eighty":42.477881,"marketCap":3051096603.42},{"date":"2026-03-27","current":212.798758,"twenty":-94.261506,"median":29.339504,"eighty":42.556524,"marketCap":2902003820.96},{"date":"2026-04-02","current":208.384924,"twenty":-94.231623,"median":29.434134,"eighty":42.704353,"marketCap":2827964511.21},{"date":"2026-04-10","current":220.172459,"twenty":-94.221662,"median":29.66191,"eighty":42.891084,"marketCap":3007447997.08},{"date":"2026-04-17","current":223.288107,"twenty":-94.186798,"median":29.795983,"eighty":43.045296,"marketCap":3074984579.03},{"date":"2026-04-24","current":242.189704,"twenty":-94.117071,"median":29.911027,"eighty":43.246201,"marketCap":3342818367},{"date":"2026-05-01","current":228.844345,"twenty":-94.057305,"median":30.049577,"eighty":43.475217,"marketCap":3174723129.99},{"date":"2026-05-08","current":246.272749,"twenty":-94.027422,"median":30.199294,"eighty":43.611845,"marketCap":3409841478.72},{"date":"2026-05-15","current":231.205429,"twenty":-93.952714,"median":30.334384,"eighty":43.895086,"marketCap":3179217752.6},{"date":"2026-05-22","current":235.985407,"twenty":-93.748512,"median":30.478219,"eighty":44.315916,"marketCap":3232400113.88},{"date":"2026-05-29","current":57.523315,"twenty":-93.439719,"median":30.583758,"eighty":44.536606,"marketCap":2984982176.15},{"date":"2026-06-05","current":53.770604,"twenty":-93.135906,"median":30.673837,"eighty":44.890309,"marketCap":2770878710.36},{"date":"2026-06-12","current":51.072486,"twenty":-93.021354,"median":30.757144,"eighty":44.999546,"marketCap":2612540227.64},{"date":"2026-06-18","current":54.770414,"twenty":-92.961588,"median":30.922991,"eighty":45.218949,"marketCap":2776051661.63},{"date":"2026-06-26","current":54.729326,"twenty":-92.961588,"median":31.108842,"eighty":45.537083,"marketCap":2762476455.87},{"date":"2026-07-02","current":55.98936,"twenty":-92.901822,"median":31.326328,"eighty":45.76965,"marketCap":2827451643.92},{"date":"2026-07-10","current":53.811692,"twenty":-92.866958,"median":31.73976,"eighty":46.016467,"marketCap":2721009214.95},{"date":"2026-07-17","current":53.551467,"twenty":-92.822133,"median":32.079,"eighty":46.098264,"marketCap":2732558690.37},{"date":"2026-07-24","current":51.017702,"twenty":-92.752406,"median":32.332694,"eighty":46.164576,"marketCap":2593422796.68},{"date":"2026-07-31","current":51.414887,"twenty":-92.662756,"median":32.619157,"eighty":46.2585,"marketCap":2628572436.16},{"date":"2026-08-07","current":58.956307,"twenty":-92.598009,"median":32.916928,"eighty":46.323119,"marketCap":1983485975},{"date":"2026-08-14","current":57.723341,"twenty":-92.573107,"median":33.048853,"eighty":46.623309,"marketCap":1954834878.45},{"date":"2026-08-21","current":54.764224,"twenty":-92.548204,"median":33.191812,"eighty":46.869356,"marketCap":1877081843.92},{"date":"2026-08-28","current":55.175212,"twenty":-92.433652,"median":33.233174,"eighty":47.274981,"marketCap":1879054542.77},{"date":"2026-09-04","current":55.524552,"twenty":-92.334041,"median":33.3614,"eighty":47.893058,"marketCap":1901224013.26},{"date":"2026-09-11","current":54.16829,"twenty":-92.274275,"median":33.413307,"eighty":48.149711,"marketCap":1850663349.86},{"date":"2026-09-14","current":54.558729,"twenty":-92.254352,"median":33.415912,"eighty":48.206457,"marketCap":1850916321.27}],"updateTime":1789488565276},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATS\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638766448","title":"GUIDANCE: (ATS) ATS Expects Fiscal Q1 Revenue Range CA$700M to CA$740M","url":"https://stock-news.laohu8.com/highlight/detail?id=2638766448","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638766448?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:11","pubTimestamp":1779963074,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ATS) ATS Expects Fiscal Q1 Revenue Range CA$700M to CA$740M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CA","ATS","ATS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638908664","title":"Earnings Flash (ATS) ATS Posts Fiscal Q4 Revenue CA$747.1M","url":"https://stock-news.laohu8.com/highlight/detail?id=2638908664","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638908664?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:09","pubTimestamp":1779962995,"startTime":"0","endTime":"0","summary":"Earnings Flash (ATS) ATS Posts Fiscal Q4 Revenue CA$747.1M","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ATS.AU","CA","ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638664599","title":"ATS Q4 Adj. EPS $0.36 Beats $0.32 Estimate, Sales $744.300M Beat $546.610M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2638664599","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638664599?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:03","pubTimestamp":1779962601,"startTime":"0","endTime":"0","summary":"ATS (NYSE:ATS) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.32 by 12.5 percent. This is a 24.14 percent increase over earnings of $0.29 per share from the same period","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52831600/ats-q4-adj-eps-0-36-beats-0-32-estimate-sales-744-300m-beat-546-610m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638466108","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2638466108","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638466108?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:00","pubTimestamp":1779962400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COST","LI","AVGO","KSS","FUTU","ODD","PD","PLAB","PICS","PATH","BBW","ADSK","GAP","BURL","DCI","PANW","CGNT","CRDO","DELL","FUFU","AMBA","NTAP","NTSK","ATS","DOO","HQY","OLLI","CXM","GCO","DLTR","LE","FIVE","MDT","KNOP","OKTA","DSGX","CRWD","HPE","MDB","CM","ASAN","ESTC","DG","AEO","ATHM","CHPT","HRL","GTLB","MRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638166486","title":"Press Release: ATS Reports Fourth Quarter Fiscal 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2638166486","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638166486?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:00","pubTimestamp":1779962400,"startTime":"0","endTime":"0","summary":"ATS Corporation   today reported its financial results for the three and twelve months ended March 31, 2026. All references to \"$\" or \"dollars\" in this news release are to Canadian dollars unless otherwise indicated.--  Net loss was $16.2 million compared to net loss $68.9 million a year. --  Basic loss per share were 16 cents, compared to loss per share of 70. --  Adjusted EBITDA1 was $102.5 million compared to $97.1 million a year. \"Today ATS reported fourth quarter and full-year results for fiscal 2026, with full-year revenue and adjusted earnings from operations growth of approximately 11%, reflecting solid execution across the platform,\" said Doug Wright, Chief Executive Officer. \"In the quarter, we took decisive steps to restructure and reposition our transportation-related businesses; we are consolidating certain operations and right-sizing our facility footprint, while repositioning our engineering and automation capabilities into applications where our differentiation creates ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638513337","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2638513337","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638513337?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:00","pubTimestamp":1779789600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HQY","HEI","COST","HAFN","KC","BURL","LE","CSW","AMBA","DOO","BBAR","BBY","BBW","CM","SNOW","BMA","ASAN","ATS","AZO","ESTC","A","ATHM","BBWI","DKS","FUTU","DY","HRL","GGAL","HPQ","GCO","PATH","BOX","CPRI","KNOP","GAP","HEI.A","CRM","BRZE","BMO","ESLT","HPE","ADSK","BNS","DELL","ANF","CRDO","KSS","PONY","DLTR","AEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637158318","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2637158318","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637158318?lang=en_us&edition=fundamental","pubTime":"2026-05-22 18:00","pubTimestamp":1779444000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNOW","BBWI","CRMT","HQY","CM","BBY","BMO","HPQ","BBAR","DOO","ANF","AMBA","BOX","FUTU","BMA","BURL","BNS","GCO","DELL","BBW","AEO","CPRI","DLTR","DY","A","ATS","PONY","ESLT","ESTC","AZO","ABVX","GAP","BAH","COST","DKS","FUFU","BRZE","ATHM","HEI.A","FRO","CRM","GGAL","PATH","CSW","BJ","GSL","HEI","ADSK","HAFN","ASAN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121242772","title":"Earning Preview: ATS Corp. this quarter’s revenue is expected to increase by 6.68%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1121242772","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121242772?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:49","pubTimestamp":1779331783,"startTime":"0","endTime":"0","summary":"Abstract ATS Corp. will report its quarterly results on May 28, 2026 Pre-Market; this preview compiles the latest financial data and forecasts, highlighting expected revenue and earnings trends...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: ATS Corp. this quarter’s revenue is expected to increase by 6.68%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636826153","title":"MiNK Therapeutics reports new data on agenT-797 at ATS 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636826153","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636826153?lang=en_us&edition=fundamental","pubTime":"2026-05-20 23:15","pubTimestamp":1779290148,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics (INKT) announced new clinical and translational data presented at the American Thoracic Society International Conference 2026 and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-reports-new-data-on-agent-797-at-ats-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-reports-new-data-on-agent-797-at-ats-2026-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATS","BK4139","INKT","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636265708","title":"MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=2636265708","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636265708?lang=en_us&edition=fundamental","pubTime":"2026-05-20 23:07","pubTimestamp":1779289620,"startTime":"0","endTime":"0","summary":"agenT-797 demonstrates pathogen suppression, lung immune restoration and tissue repair activation, supporting Ongoing Phase 2 trialSequential immunotherapy with agenT-797 and N-803, an FDA-approved IL","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/20/3298712/0/en/MiNK-Therapeutics-Reports-New-Data-on-agenT-797-an-allo-iNKT-Cell-Therapy-at-ATS-2026-Simultaneously-Published-in-Clinical-Immunology-Communications.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARDS","ATS","INKT","BK4139","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636842847","title":"Savara presents poster at ATS 2026 International Conference on IMPALA-2","url":"https://stock-news.laohu8.com/highlight/detail?id=2636842847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636842847?lang=en_us&edition=fundamental","pubTime":"2026-05-20 20:22","pubTimestamp":1779279748,"startTime":"0","endTime":"0","summary":"Savara (SVRA) presented a poster at the ATS 2026 International Conference that is taking place May 15-20, 2026, in Orlando, Florida. The poster rep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/savara-presents-poster-at-ats-2026-international-conference-on-impala-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/savara-presents-poster-at-ats-2026-international-conference-on-impala-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SVRA","ATS","BK4161","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636899581","title":"Entravision Rides ATS Surge in Latest Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2636899581","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636899581?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:39","pubTimestamp":1779241157,"startTime":"0","endTime":"0","summary":"Entravision Communications Corporation Class A (($EVC)) has held its Q1 earnings call. Read on for the main highlights of the call. Entravision Com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/entravision-rides-ats-surge-in-latest-earnings-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/entravision-rides-ats-surge-in-latest-earnings-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVC","ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636968860","title":"BLUE OCEAN TECHNOLOGIES APPOINTS WILLIAM GOODBODY, JR. AS HEAD OF MARKET OPERATIONS FOR BLUE OCEAN ATS IN AUSTRALIA","url":"https://stock-news.laohu8.com/highlight/detail?id=2636968860","media":"prnewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636968860?lang=en_us&edition=fundamental","pubTime":"2026-05-20 06:35","pubTimestamp":1779230100,"startTime":"0","endTime":"0","summary":"Strategic Appointment Expands Blue Ocean Technologies' Presence Across the APAC Region. Bill brings more than 30 years of experience spanning global equities, foreign exchange, and digital assets across major financial centers in the United States, Europe, and APAC. Throughout his career, he has held senior leadership positions at globally recognized firms including Bats Global Markets, Hotspot FX, Knight Capital Group, AE Capital, and Zerocap.Brian Hyndman, CEO of Blue Ocean Technologies commented, \"Bill's deep operational expertise, institutional market knowledge, and extensive capital markets experience building and scaling global trading businesses make him an exceptional addition to the Blue Ocean ATS team. In his new role, Bill will focus on enhancing operational capabilities, supporting strategic partnerships, and accelerating Blue Ocean Technologies' growth initiatives throughout APAC. This appointment marks an important milestone in our international growth strategy as we cont","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/blue-ocean-technologies-appoints-william-goodbody-jr-as-head-of-market-operations-for-blue-ocean-ats-in-australia-302776886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK4024","BOT.AU","ATS","BK4161","BK7502","BOT","BK7508","FOR","NMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636866149","title":"Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2636866149","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636866149?lang=en_us&edition=fundamental","pubTime":"2026-05-20 02:15","pubTimestamp":1779214500,"startTime":"0","endTime":"0","summary":"ORCA-OL data complete the clinical evidence package supporting the cytisinicline smoking cessation NDA No new safety signals identified by the independent Data Safety Monitoring Committee over 52 week","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/19/3297888/0/en/Achieve-Life-Sciences-Presents-Safety-Data-from-52-Weeks-of-Continuous-Cytisinicline-Treatment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636970009","title":"Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636970009","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636970009?lang=en_us&edition=fundamental","pubTime":"2026-05-19 04:30","pubTimestamp":1779136200,"startTime":"0","endTime":"0","summary":"Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with mo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/18/3297034/0/en/Wave-Life-Sciences-Announces-Positive-Update-on-RestorAATion-2-Trial-WVE-006-GalNAc-RNA-Editing-Achieves-MZ-Like-Phenotype-Across-Both-Biweekly-and-Monthly-Dosing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0009354923.USD","BK4161","BK4505","BK4007","WVE","BK4139","ATS","RNA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636072000","title":"Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2636072000","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636072000?lang=en_us&edition=fundamental","pubTime":"2026-05-18 23:30","pubTimestamp":1779118200,"startTime":"0","endTime":"0","summary":"– Verekitug led to statistically significant and clinically meaningful improvement in asthma symptom control as measured by the Asthma Control Questionnaire-6 (ACQ-6) in participants with CRSwNP and c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/18/3296828/0/en/Upstream-Bio-Presents-New-Data-from-Phase-2-VIBRANT-Trial-of-Verekitug-Demonstrating-Improvement-in-Asthma-Symptom-Control-in-Participants-with-CRSwNP-and-Comorbid-Asthma-at-the-AT.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636072503","title":"ATS Corporation Sets May 28, 2026 Fourth-Quarter Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2636072503","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636072503?lang=en_us&edition=fundamental","pubTime":"2026-05-18 22:47","pubTimestamp":1779115643,"startTime":"0","endTime":"0","summary":"The latest update is out from ATS Corporation ( ($TSE:ATS) ). ATS Corporation said on May 14, 2026, that it will release financial results for its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ats-corporation-sets-may-28-2026-fourth-quarter-earnings-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ats-corporation-sets-may-28-2026-fourth-quarter-earnings-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635034943","title":"Wave Life Sciences ATS Data Could Support RNA Editing Platform, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2635034943","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635034943?lang=en_us&edition=fundamental","pubTime":"2026-05-16 02:40","pubTimestamp":1778870414,"startTime":"0","endTime":"0","summary":"Wave Life Sciences  is expected to present new data from its RestorAATion-2 study of WVE-006 at the ATS 2026 conference that could further strengthen confidence in its RNA editing platform, Wedbush Securities said in a note Friday.The brokerage said in a Friday research note that the upcoming results could show a consistent improvement pattern versus earlier cohorts, including higher editing efficiency and sustained protein responses across dose groups.The investment firm added that the data may support clinically meaningful levels of alpha-1 antitrypsin production. It added that the durability of the response could enable monthly or less frequent dosing intervals.Wedbush has an outperform rating and a $15 price target on Wave Life Sciences.Shares of the company were down 2.6% in Friday trading.Price: 6.72, Change: -0.18, Percent Change: -2.61","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009354923.USD","BK4588","BK4505","BK4007","ATS","BK4139","RNA","BK4585","WVE","BK4161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635899440","title":"Press Release: MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2635899440","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635899440?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:30","pubTimestamp":1778844600,"startTime":"0","endTime":"0","summary":"-- Randomized Phase 2 trial initiated for agenT-797 in severe acute lung. injury and respiratory distress, with preliminary data expected in the. -- AACR and ASGCT presentations showcase durable survival and. context-dependent iNKT activity in cancer and inflammatory lung disease. -- Non-dilutive collaborations expand MiNK's platform and potentiate. meaningful commercial revenue potential, while preserving focus on lead. Dr. Buell continued, \"What continues to distinguish agenT-797 is both its biology and its practicality. As an off-the-shelf iNKT cell therapy administered without lymphodepletion or HLA matching, agenT-797 is designed for settings where immune dysfunction drives poor outcomes and where speed, tolerability and deployability matter. We believe this is particularly relevant in severe acute lung injury and critical illness, where patients often face a cascade of respiratory failure, secondary infection and organ dysfunction with limited therapeutic options.\". MiNK initiate","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139","BK4161","ATS","INKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635086190","title":"Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses","url":"https://stock-news.laohu8.com/highlight/detail?id=2635086190","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635086190?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:00","pubTimestamp":1778842800,"startTime":"0","endTime":"0","summary":"Late-breaking presentation at SID and featured presentation at the ATS Respiratory Innovation Summit highlight KT-621 BroADen Phase 1b clinical data and potential across Type 2 inflammatory diseases K","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/15/3295720/0/en/Kymera-Therapeutics-Announces-Presentations-on-KT-621-a-First-In-Class-Oral-STAT6-Degrader-at-the-Society-for-Investigative-Dermatology-and-American-Thoracic-Society-Congresses.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","BK4588","KYMR","BK4096","LU1829250122.USD","BK4006","BP","LU1162221912.USD","SG9999004220.SGD","BK4201","BPH","LU0006061336.USD","BK4139","LU0541501648.USD","LU0072461881.USD","BK4115","SID","BK4107","AFG","LU0300736492.USD","PN","BK4132","LU0541502299.USD","BK4585","KT","LU0300736062.USD","BK4161","AD","BK4117","LU0162691827.USD","ATS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":113,"code":"91000000","status":"200"}]}}